Publikationen von S Lucae
Alle Typen
Zeitschriftenartikel (195)
2016
Zeitschriftenartikel
6, e950 (2016)
Proliferation rates and gene expression profiles in human lymphoblastoid cell lines from patients with depression characterized in response to antidepressant drug therapy. TRANSLATIONAL PSYCHIATRY
Zeitschriftenartikel
71 (1), S. 115 - 118 (2016)
IgE responses to exogenous and endogenous allergens in atopic dermatitis patients under long-term systemic cyclosporine A treatment. ALLERGY 2015
Zeitschriftenartikel
5, e678 (2015)
Genome-wide analysis implicates microRNAs and their target genes in the development of bipolar disorder. TRANSLATIONAL PSYCHIATRY
Zeitschriftenartikel
25 (6), S. 864 - 872 (2015)
IGF-I in major depression and antidepressant treatment response. EUROPEAN NEUROPSYCHOPHARMACOLOGY
Zeitschriftenartikel
20 (6), S. 735 - 743 (2015)
The association between lower educational attainment and depression owing to shared genetic effects? Results in similar to 25 000 subjects. MOLECULAR PSYCHIATRY
Zeitschriftenartikel
13, 86 (2015)
A genetic risk score combining 32 SNPs is associated with body mass index and improves obesity prediction in people with major depressive disorder. BMC MEDICINE
Zeitschriftenartikel
5, e538 (2015)
RNA expression profiling in depressed patients suggests retinoid-related orphan receptor alpha as a biomarker for antidepressant response. Translational psychiatry
Zeitschriftenartikel
18 (2), S. 199 - 209 (2015)
Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways. NATURE NEUROSCIENCE
Zeitschriftenartikel
8 (404), S. ra119 - ra119 (2015)
Chaperoning epigenetics: FKBP51 decreases the activity of DNMT1 and mediates epigenetic effects of the antidepressant paroxetine. Science signaling
Zeitschriftenartikel
40 (2), S. 361 - 371 (2015)
XRCC5 as a Risk Gene for Alcohol Dependence: Evidence from a Genome-Wide Gene-Set-Based Analysis and Follow-up Studies in Drosophila and Humans. NEUROPSYCHOPHARMACOLOGY
Zeitschriftenartikel
76 (6), S. e802 - e808 (2015)
Clinical risk factors for weight gain during psychopharmacologic treatment of depression: results from 2 large German observational studies. The Journal of clinical psychiatry
Zeitschriftenartikel
16 (7), S. 689 - 701 (2015)
CHL1, ITGB3 and SLC6A4 gene expression and antidepressant drug response: results from the Munich Antidepressant Response Signature (MARS) study. PHARMACOGENOMICS 2014
Zeitschriftenartikel
11 (11), e1001755 (2014)
Association of FKBP51 with Priming of Autophagy Pathways and Mediation of Antidepressant Treatment Response: Evidence in Cells, Mice, and Humans. PLOS MEDICINE
Zeitschriftenartikel
76 (7), S. E15 - E17 (2014)
Blood Mononuclear Cell Proteome Suggests Integrin and Ras Signaling as Critical Pathways for Antidepressant Treatment Response. BIOLOGICAL PSYCHIATRY
Zeitschriftenartikel
165 (5), S. 428 - 437 (2014)
Genetic Relationships Between Suicide Attempts, Suicidal Ideation and Major Psychiatric Disorders: A Genome-Wide Association and Polygenic Scoring Study. AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS
Zeitschriftenartikel
19 (2), S. 165 - 175 (2014)
The clinical application of ABCB1 genotyping in antidepressant treatment: a pilot study. CNS SPECTRUMS
Zeitschriftenartikel
5, 3339 (2014)
Genome-wide association study reveals two new risk loci for bipolar disorder. NATURE COMMUNICATIONS
Zeitschriftenartikel
155, S. 81 - 89 (2014)
Investigating the genetic variation underlying episodicity in major depressive disorder: Suggestive evidence for a bipolar contribution. JOURNAL OF AFFECTIVE DISORDERS
Zeitschriftenartikel
4, e352 (2014)
Plasma fibrinogen: now also an antidepressant response marker? TRANSLATIONAL PSYCHIATRY 2013
Zeitschriftenartikel
23 (11), S. 1503 - 1515 (2013)
Prediction of antidepressant treatment response from gray matter volume across diagnostic categories. EUROPEAN NEUROPSYCHOPHARMACOLOGY